In recent years, cancer researchers have hailed the arrival of chimeric antigen receptor T-cell (CAR T) therapy, which has delivered promising results, transforming the fight against various forms of cancer.
The process involves modifying patients’ T-cells to target cancer cells, resulting in remarkable success rates for previously intractable forms of cancer.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
